Introduction
In recent years, the global ophthalmic viscoelastic devices market has been rapidly expanding, driven by the increasing prevalence of cataract and glaucoma surgeries, an aging population, and the rising demand for safe and effective ocular materials. Among the latest innovations in this field, the use of biocompatible materials such as sodium hyaluronate has become central to ensuring both safety and performance during ophthalmic procedures.
What Are Ophthalmic Viscoelastic Devices?
OVDs are specialized polymer solutions used to maintain space in the anterior chamber of the eye during surgeries such as cataract extraction, intraocular lens implantation, corneal transplantation, and glaucoma filtration procedures. They help surgeons protect delicate ocular tissues-particularly the corneal endothelium-by minimizing friction, absorbing mechanical shock, and ensuring exceptional optical clarity throughout surgery.
OVDs can generally be divided into two types: cohesive and dispersive. Singclean's sodium hyaluronate-based OVD is a cohesive type, designed to create and maintain space effectively while being easily removed after surgery-reducing the risk of postoperative intraocular pressure elevation.
The Role of Sodium Hyaluronate in Biocompatibility
At the core of modern OVD technology lies sodium hyaluronate, a naturally occurring polysaccharide found in the human body. Its excellent biocompatibility, viscoelasticity, and transparency make it an ideal substance for ophthalmic applications. Singclean's OVD solution is derived from bacterial fermentation, ensuring no animal origin, no pyrogen, and no rejection reaction-critical attributes for minimizing patient risk.
Singclean's formulation contains a high molecular weight sodium hyaluronate (1,000,000–2,600,000 Daltons) at a concentration of 15 mg/mL, dissolved in a balanced sodium phosphate buffer. This structure not only stabilizes the anterior chamber during surgery but also helps absorb mechanical stress from ultrasound energy during phacoemulsification, thereby reducing potential endothelial cell damage.
Meeting European and Global Safety Standards
As a CE 2460-certified medical device, Singclean's ophthalmic viscoelastic gel adheres to rigorous European quality and safety standards. The company's production environment meets 10,000-level cleanroom and local 100-level aseptic conditions, ensuring the sterility and purity of each batch. Every product undergoes lamp inspection to eliminate impurities and guarantee the high transparency essential for precise surgical vision.
Moreover, the final product is sterilized using high-pressure moist heat, providing an additional layer of safety. This combination of advanced manufacturing, quality assurance, and strict regulatory compliance underscores Singclean's commitment to producing OVDs that meet both clinical and international expectations.
Clinical and Market Validation
According to post-market clinical data collected from 2015–2023, no adverse events or product recalls have been reported from Singclean's ophthalmic viscoelastic products, reflecting excellent patient and physician satisfaction. Over 1.4 million units have been distributed across global markets including China, the UK, Malaysia, Germany, South Africa, and the EU. Feedback from ophthalmic surgeons consistently highlights the gel's high safety profile, smooth handling, and excellent surgical performance.
As per recent market forecasts, the global OVD market is expected to reach USD 1.27 billion by 2028, growing at a CAGR of approximately 10.18%. With cataract and glaucoma surgeries on the rise worldwide, biocompatible and high-quality OVDs such as Singclean's are poised to play a pivotal role in the next phase of ophthalmic innovation.
Sustainable Innovation and the Future of Eye Surgery
Beyond clinical performance, the use of fermentation-derived sodium hyaluronate aligns with the medical industry's growing emphasis on sustainability and biocompatibility. Singclean's ophthalmic OVD exemplifies how green biotechnology can coexist with cutting-edge medical technology, delivering safer, cleaner, and more effective surgical outcomes.
As ophthalmic surgery continues to evolve toward minimally invasive and patient-centered approaches, the demand for biocompatible, CE-certified viscoelastic materials will continue to shape the market. Singclean remains at the forefront of this transformation, empowering surgeons worldwide with reliable, high-performance solutions designed to enhance both surgical precision and patient recovery.
About Singclean Medical
Founded in Hangzhou, China, Singclean Medical is a leading manufacturer of biomedical materials and medical devices specializing in sodium hyaluronate-based solutions for ophthalmic, orthopedic, and aesthetic applications. With over a decade of global market experience and CE, ISO13485, and GMP certifications, Singclean is committed to delivering safe, innovative, and eco-friendly healthcare products to over 70 countries worldwide.
Learn more at www.singclean.org.
